Evaluation of the SARS-CoV-2-IgG response in outpatients by five commercial immunoassaysArticle Published on 2020-09-162022-10-31 Journal: GMS Infectious Diseases [Category] COVID-19, [키워드] Abbott ambulatory patients antibody Antibody Response Antigen assays association Asymptomatic collected commercial immunoassay Contact COVID-19 detect Elecsy evaluated FIVE Follow-up hospitalized COVID-19 patients hospitalized patients IgG IgG ELISA IgG response immunoassay immunoassays median novel onset of symptoms Outpatient Patient PCR-positive reported Roche S protein S1/S2 SARS-CoV-2 SARS-CoV-2 IgG SARS-CoV-2-IgG sensitivity serology serum sample serum samples Seven total antibody while [DOI] 10.3205/id000066 PMC 바로가기 [Article Type] Article
Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID-19 Patients혈청학적 분석, 회복된 COVID-19 환자에서 매우 가변적인 SARS-CoV-2 중화 항체 활성 추정Immunoassays Published on 2020-09-112022-09-10 Journal: Journal of Clinical Microbiology [Category] SARS, 진단, 치료기술, [키워드] 2019 Abbott Abbott SARS-CoV-2 IgG Accuracy activity acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 anti-SARS-CoV-2 antibody antiviral activity center choice collected convalescent plasma convalescent plasma samples coronavirus coronavirus disease correlated COVID-19 Critical determine Donor ELISA ELISAs enrolled enzyme enzyme-linked immunosorbent assay enzyme-linked immunosorbent assays estimate gold gold standard house IgG Immunity immunoglobin Infection Interpretation levels of antibodies levels of antibody methodology NAb NAb activity NAb assay NAb assays NAbs neutralization Neutralizing antibodies neutralizing antibody New York offer pandemic Particles patient sera Population population immunity predict Program proportion Pseudotyped virus recovered reopening respiratory SARS-CoV-2 SARS-CoV-2 detection Sensitivity and specificity serologic tests Serological assay serological assays serological measurement serological measurements serological test Serological tests serology Seroprevalence severe acute respiratory syndrome Coronavirus therapeutic therapeutic trials total Ig Trial unique vaccination variable Variation Viral viral infection [DOI] 10.1128/JCM.02005-20 PMC 바로가기 [Article Type] Immunoassays
COVID-19 Infection Diagnosis: Potential Impact of Isothermal Amplification Technology to Reduce Community Transmission of SARS-CoV-2Review Published on 2020-06-112022-10-31 Journal: Diagnostics [Category] COVID-19, [키워드] 2019-nCoV Abbott amplification clinics Community community transmission comparable coronavirus disease COVID-19 detect driven by effective example help hospitals Impact isothermal isothermal amplification Laboratory LAMP less NEAR Nicking Novel coronavirus pandemic PCR performed platform point of care testing polymerase Potential provide Rapid test rapid testing required resource RNA extraction RPA RT-PCR test SARS-CoV-2 SARS-CoV-2 detection scaled up Scientific community shown Spread spread of COVID-19 Support technology USA virus [DOI] 10.3390/diagnostics10060399 PMC 바로가기 [Article Type] Review
Performance Characteristics of the Abbott Architect SARS-CoV-2 IgG Assay and Seroprevalence in Boise, IdahoImmunoassays Published on 2020-05-072022-10-30 Journal: Journal of Clinical Microbiology [Category] COVID-19, SARS, [키워드] Abbott Abbott SARS-CoV-2 IgG acute respiratory syndrome anti-SARS-CoV-2 IgG antibody Architect caused circulation Cohort collected coronavirus Coronavirus disease 2019 COVID COVID-19 Curve determine diagnostic evaluated False positive Idaho individual infections morbidity and mortality Patient PCR positivity performance populations positive reached Respiratory illness reverse transcription-PCR RT-PCR SARS SARS-CoV-2 SARS-CoV-2 IgG sensitivity Serological testing serology Seroprevalence serum specificity specimen symptom onset tested the United State threshold United States virus [DOI] 10.1128/JCM.00941-20 PMC 바로가기 [Article Type] Immunoassays
Current and emerging diagnostic tests available for the novel COVID-19 global pandemicOpen Letter Published on 2020-04-242022-10-28 Journal: AAS Open Research [Category] COVID-19, [키워드] Abbott approaches caused clearance coronavirus coronavirus disease COVID-19 COVID-19 test current Diagnosis diagnostic test drug Emergency use authorization Epidemic food Genome sequencing global pandemic Infection Novel coronavirus outbreak point-of-care diagnostic tests point-of-care test Rapid diagnostic test SARS-CoV-2 SARS-CoV-2 test WHO World Health Organization [DOI] 10.12688/aasopenres.13059.1 PMC 바로가기 [Article Type] Open Letter
Clinical Evaluation of Three Sample-to-Answer Platforms for Detection of SARS-CoV-2Virology Published on 2020-04-242022-10-30 Journal: Journal of Clinical Microbiology [Category] COVID-19, SARS, [키워드] Abbott acute respiratory syndrome Analysis analytical sensitivity assays Cepheid clinical coronavirus COVID-19 Critical detection determine diagnostic drug EUA evaluate FDA food globe highest identify limit of detection lowest molecular molecular diagnostics nasopharyngeal Nasopharyngeal swab near-patient testing platform positive produced reference standard SARS-CoV-2 SARS-CoV-2 positive patients specimen Spread Symptomatic patients Test [DOI] 10.1128/JCM.00783-20 PMC 바로가기 [Article Type] Virology
Comparison of Abbott ID Now and Abbott m2000 Methods for the Detection of SARS-CoV-2 from Nasopharyngeal and Nasal Swabs from Symptomatic PatientsLetter to the Editor Published on 2020-04-232022-10-30 Journal: Journal of Clinical Microbiology [Category] COVID-19, SARS, [키워드] Abbott COVID-19 detection diagnostic testing NAAT point of care SARS-CoV-2 [DOI] 10.1128/JCM.00798-20 PMC 바로가기 [Article Type] Letter to the Editor
Comparison of Abbott ID Now, DiaSorin Simplexa, and CDC FDA Emergency Use Authorization Methods for the Detection of SARS-CoV-2 from Nasopharyngeal and Nasal Swabs from Individuals Diagnosed with COVID-19Letter to the Editor Published on 2020-04-172022-10-30 Journal: Journal of Clinical Microbiology [Category] COVID-19, SARS, [키워드] in vitro diagnostic Abbott authorization CDC coronavirus COVID-19 detection DiaSorin Emergency Emergency use authorization FDA individual nucleic acid amplification SARS-CoV-2 Virology with COVID-19 [DOI] 10.1128/JCM.00760-20 PMC 바로가기 [Article Type] Letter to the Editor
In Vitro Diagnostic Assays for COVID-19: Recent Advances and Emerging TrendsEditorial Published on 2020-04-052022-10-31 Journal: Diagnostics [Category] COVID-19, [키워드] Abbott acute respiratory syndrome advance approved automated caused Cepheid CLIA Clinical diagnosis complement complementary coronavirus coronavirus disease COVID-19 detect diagnosis of COVID-19 diagnostic diagnostics drug effort ELISA Emergency use authorization EUA evaluated FDA food IgG IgM immunoassay immunoassays Immunoglobulin in vitro IVD lateral flow Lateral flow immunoassay (LFIA) LFIA molecular Molecular assay molecular test MOST POC point-of-care Point-of-Care (POC) polymerase chain produced real-time reverse transcriptase real-time reverse transcriptase polymerase chain (RT-PCR) recent Research RT-PCR SARS-CoV-2 SARS-COV-2 infection serology the United State trend [DOI] 10.3390/diagnostics10040202 PMC 바로가기 [Article Type] Editorial